Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
5-Azacytidine Beyond Oncology: An Epigenetic Strategy
2026-09-11
A translational perspective on how 5-Azacytidine can connect DNMT inhibition, DNA demethylation, cell-state control, and emerging UHRF1–5-mC biology while defining the evidence, experimental safeguards, and limits of extending oncology findings into senile osteoporosis research.
-
HyperScribe™ Poly (A) Tailing Kit Workflow
2026-09-11
Convert compatible in vitro-transcribed RNA into material better suited to stability-sensitive expression studies, transfection experiments, and micro-injection. This workflow combines controlled enzymatic polyadenylation with assay-specific quality checks, including a practical route for testing TCAIM–OGDH metabolic regulation.
-
7-AAD Cell Viability Assay Kit for CD38 CAR-T
2026-09-10
Apply membrane-integrity measurements to distinguish CD38 CAR-T cytotoxicity from fratricide and late cell death. This practical workflow combines 7-AAD with Annexin V, Calcein AM, and immunophenotyping to turn structural binder design into interpretable cellular evidence.
-
Dual HER2–VEGFR-2 Targeting in Breast Cancer
2026-09-10
A 2026 study evaluated Lapatinib and Telatinib in HER2-negative MDA-MB-231 triple-negative breast cancer cells, linking dual tyrosine kinase inhibition with reduced proliferation, invadopodia formation, and two-dimensional tube formation. The findings support phenotype-first targeted cancer therapy research while leaving direct receptor engagement and combination synergy unresolved.
-
Tubastatin A: HDAC6 Inhibitor Workflow
2026-09-09
Tubastatin A enables selective HDAC6 inhibition while linking α-tubulin acetylation to cell stress, inflammatory signaling, and regulated cell death. This practical workflow translates porcine cardiac-arrest findings into reproducible cell assays, biomarker panels, and troubleshooting decisions for cancer biology and translational research.
-
Lypressin acetate: Practical Assay Workflows
2026-09-09
Lypressin acetate offers a versatile peptide-hormone tool for receptor signaling, antidiuretic biology, vasoconstriction research, and exploratory antiviral studies. This workflow-focused guide explains how to handle the peptide, build concentration–response assays, interpret activity data, and troubleshoot reproducibility problems.
-
RITA (NSC 652287): From p53 Signal to Translation
2026-09-08
A translational framework for using RITA to connect MDM2–p53 biology, DNA cross-link stress, interpretable viability metrics, and tumor xenograft evidence.
-
Cell Senescence β-Galactosidase Staining Kit Workflow
2026-09-08
Build a practical SA-β-Gal workflow for cultured cells and frozen sections, from plate setup through quantitative microscopy. The assay is especially useful for connecting pathway-directed treatments, such as HPV-16 E6 inhibition, with a visible senescence phenotype while preserving orthogonal validation.
-
ISRIB (trans-isomer): ATF4 Beyond ER Stress
2026-09-07
ISRIB (trans-isomer) is a potent PERK inhibitor and integrated stress response modulator for dissecting ATF4-dependent biology. This article explains how its eIF2B-centered mechanism can be applied to liver fibrosis, ER stress research, apoptosis assays, and carefully controlled translational models.
-
NAT10, ac4C, and OGA in Oocyte Maturation
2026-09-07
The reference study identifies an epitranscriptomic pathway in which NAT10-dependent ac4C modification stabilizes OGA mRNA and supports oocyte maturation. Its findings connect RNA modification with O-GlcNAc regulation and provide a mechanistic framework for understanding, and potentially improving, in vitro maturation outcomes.
-
KR-12 Human Antimicrobial Peptide: Bench Guide
2026-09-05
KR-12 is a compact LL-37 fragment for separating direct antimicrobial activity from biofilm, LPS, and inflammation-related effects in controlled assays. This workflow helps researchers use the TFA salt consistently, compare strain-specific responses, and troubleshoot the common gap between MIC and antibiofilm performance.
-
5-Azacytidine: From DNMT Trap to Immune Signal
2026-09-04
5-Azacytidine is more than a DNA demethylation agent: its chromatin effects can influence viral mimicry and antitumor immunity. This article translates recent PTEN-deficient glioblastoma findings into practical assay and interpretation strategies.
-
7-AAD Cell Viability Assay Kit for CAR-T Studies
2026-09-04
The 7-AAD Cell Viability Assay Kit provides a red-fluorescent membrane-integrity readout for necrotic and late apoptotic cells. As a 7-amino actinomycin D assay, it complements CD38 CAR-T studies by quantifying cell death while preserving multiplexing options with Annexin V and Calcein AM.
-
Adiponectin, TLR4, and Cognitive Deficits in Aged Rats
2026-09-03
A Research Square study links adiponectin-mediated protection against splenectomy-induced cognitive deficits to suppression of the TLR4/MyD88/NF-κB axis, reduced oxidative stress, and lower microglial inflammation. Its pharmacological rescue-and-blockade design provides a useful framework for evaluating perioperative neurocognitive disorder mechanisms while highlighting the need for broader validation.
-
ANP as a Translational Lever in Cardiovascular Research
2026-09-03
A mechanistic and strategic guide to using rat Atrial Natriuretic Peptide in cardiovascular, renal, and metabolic research while preserving a critical distinction between ANP and adiponectin. The article translates findings from an aged-rat neuroinflammation study into better controls, identity documentation, and target-engagement strategies for ANP workflows.